Retrospective Study
Copyright ©The Author(s) 2025.
World J Gastrointest Surg. Jun 27, 2025; 17(6): 104545
Published online Jun 27, 2025. doi: 10.4240/wjgs.v17.i6.104545
Table 2 Comparison of general information between two groups of patients, n (%)
Project
Chemotherapy ineffective group (n = 35) (tumor residual ≥ 50%)
Chemotherapy effective group (n = 62) (tumor residual < 50%)
t/χ2
P value
Age62.35 + 8.4261.87 + 9.130.2580.797
Gender0.3420.559
    Male24 (68.57)39 (62.90)
    Female11 (31.43)23 (37.10)
Staging0.8760.349
    Stage II13 (37.14)29 (46.77)
    Stage III22 (62.86)33 (53.23)
Location0.5230.470
    Cardia15 (42.86)31 (50.00)
    Gastric body20 (57.14)31 (50.00)
Lauren's classification1.2470.536
    Diffuse type14 (40.00)21 (33.87)
    Mixed type8 (22.86)19 (30.65)
    Intestinal type13 (37.14)22 (35.48)